Yahoo Canada Web Search

Search results

  1. BIIB - Biogen Inc.

    Yahoo Finance

    228.07+2.42 (+1.07%)

    at Mon, Jul 8, 2024, 4:00PM EDT - U.S. markets closed

    After Hours 226.59 -1.48 (-0.65%)

    Nasdaq Real Time Price

    • Open 226.47
    • High 229.41
    • Low 225.80
    • Prev. Close 225.65
    • 52 Wk. High 282.74
    • 52 Wk. Low 189.44
    • P/E 28.47
    • Mkt. Cap 33.21B
  2. 7 hours ago · If you purchased or acquired Biogen securities, and/or would like to discuss your legal rights and options please visit Biogen Inc. Shareholder Class Action Lawsuit or contact Investor Relations ...

  3. 22 hours ago · Biogen and Eisai's ADUHELM was granted accelerated approval by the FDA for treating early Alzheimer's disease, including mild cognitive impairment due to Alzheimer's. It is the first treatment to ...

  4. 22 hours ago · Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Biogen To Contact Him Directly To Discuss Their Options If you ...

  5. 7 hours ago · If you purchased or acquired Biogen securities, and/or would like to discuss your legal rights and options please visit Biogen Inc. Shareholder Class Action Lawsuit or contact Investor Relations ...

  6. 6 hours ago · LOS ANGELES, July 8, 2024 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against...

  7. 22 hours ago · Another biosimilar developed by Polpharma is Biogen’s Tysabri (natalizumab) biosimilar, Tyruko. The biosimilar is licensed to Sandoz , which bears responsibility for distribution and ...

  8. People also ask

  9. 22 hours ago · The class action complaint against Biogen, Gray v. Biogen Inc., et al., Case No. 24-cv-01444, is filed in the United States District Court for the District of Colorado.

  1. People also search for